TILTAN PHARMA
One of the major advances in cancer research over the past decade has been the realization that tumor growth is dependent on the tumor's ability to recruit blood vessels from the neighboring tissue. Angiogenesis, the process by which new blood vessels are formed, is a hallmark capability of cancer, critical for the development of all solid tumors. This property is the basis for anti-angiogenic therapy, a promising novel strategy for treatment of cancer.
TILTAN PHARMA
Industry:
Biotechnology Health Care Therapeutics
Founded:
2006-01-01
Address:
Jerusalem, Yerushalayim, Israel
Country:
Israel
Website Url:
http://www.tiltanpharma.com
Total Employee:
1+
Status:
Active
Contact:
97286473836
Email Addresses:
[email protected]
Total Funding:
1.5 M USD
Technology used in webpage:
Apache Euro Google Apps For Business Typekit GoDaddy Starfield Technologies Adobe Muse Adobe Creative Cloud WebFonts
Current Employees Featured
Founder
Official Site Inspections
http://www.tiltanpharma.com Semrush global rank: 6.11 M Semrush visits lastest month: 1.33 K
- Host name: 67.89.153.160.host.secureserver.net
- IP address: 160.153.89.67
- Location: Scottsdale United States
- Latitude: 33.6013
- Longitude: -111.8867
- Metro Code: 753
- Timezone: America/Phoenix
- Postal: 85260
Loading ... 